COPD Exacerbation
183
19
23
81
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
14 trials with published results (8%)
Research Maturity
81 completed trials (44% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.7%
14 terminated out of 183 trials
85.3%
-1.3% vs benchmark
13%
24 trials in Phase 3/4
17%
14 of 81 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 81 completed trials
Clinical Trials (183)
Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease
A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD
Virtual Reality in COPD Exacerbation
Automated Oxygen Delivery by O2matic to Patients Admitted With an Exacerbation in COPD
Combination of High-flow Nasal Oxygen (Optiflow) and Vibrating Membrane Nebuliser (Aerogen) in the Pre-hospital Setting - Before/After Study
Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Patients Presenting to the Emergency Department With Acute Exacerbation of COPD (ECOPD)
PCT-guided Treatment Regarding Antibiotic Use for Acute COPD Exacerbations
Physiological and Environmental Data in a Remote Setting to Predict Exacerbation Events in Patients With Chronic Obstructive Pulmonary Disease
Early Detection of COPD Exacerbations Using Home Monitoring Device
Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Hospitalized Patients With AECOPD
Emotional-distress-based Integrated Care Programme in Patients With an Acute Exacerbation of COPD
Eosinophil-driven Corticotherapy for Patients Hospitalized for COPD Exacerbation
Innate Immunity in Ozone-induced Airway Inflammation in COPD
Multidisciplinary Management of Severe COPD
Atorvastatin Effect on Reduction of COPD Exacerbations
Predicting Adverse Outcomes Using Machine Learning of COPD Patients in Hong Kong
Comparing Mortality for Low vs High Peripheral Oxygen Saturation in COPD-patients With Acute Exacerbation
Comparison of Multiple Oxygenation Targets With Different Oximeters in Chronic Obstructive Pulmonary Disease (COPD) and Non-COPD Patients- Impact on Oxygen Flows
A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients With Mild to Moderate COPD
Eosinophil-guided Reduction of Inhaled Corticosteroids